Top News
 |
New Prosthetic Allows Each Finger to Move Separately May 13, 2008
A new prosthetic hand being tested at the Orthopedic University Hospital in Heidelberg functions almost like a natural hand, being able to hold a credit card, use a keyboard with the index finger, and lift a bag weighing up to 20 kg. |
|
Calcification score predicts amputation with peripheral arterial disease May 12, 2008
NEW YORK (Reuters Health) - The tibial artery calcification (TAC) score, assessed by multidetector CT, can identify patients with peripheral arterial disease (PAD) who are at high risk for amputation, new research shows. In fact, in this regard, the TAC score is superior to traditional risk factors and an abnormal ankle-brachial index. |
|
Reimplanting electrodes may improve STN stimulation response in Parkinson's May 12, 2008
NEW YORK (Reuters Health) - Suboptimal response to bilateral subthalamic nucleus (STN) stimulation in patients with Parkinson's disease may be caused by misplacement of electrodes by even a few millimeters. Physicians in France report that in such cases, patients may benefit from reimplantation of the electrodes closer to the theoretical target. |
|
Cognitive impairment common in pediatric MS May 12, 2008
NEW YORK (Reuters Health) - Low IQ scores and cognitive problems occur frequently in children and adolescents with multiple sclerosis, according to an Italian study reported in the May 13 issue of Neurology. |
|
Ranbaxy to develop anti-infective drugs for Merck May 12, 2008
LONDON/MUMBAI (Reuters) - India's Ranbaxy Laboratories Ltd is to develop new anti-infective drugs for Merck & Co Inc, underlining the growing use of Indian pharmaceutical research by multinational companies. |
|
Androgen deficiency may accompany erectile dysfunction May 12, 2008
NEW YORK (Reuters Health) - Androgen deficiency is quite common in men with erectile dysfunction (ED) and is associated with age and hypercholesterolemia among other factors, according to Minneapolis-based researchers. |
|
Forest ends promotion of Daiichi hypertension drug May 12, 2008
NEW YORK (Reuters) - Forest Laboratories Inc has ended its agreement with Daiichi Sankyo Co Ltd to co-promote Daiichi's blood-pressure drug Azor, as Forest shifts resources to support other products, the companies said on Monday. |
|
Physical therapists better than robots in helping stroke survivors regain mobility May 12, 2008
NEW YORK (Reuters Health) - In ambulatory stroke survivors who still have moderate to severe gait impairment after 6 months, therapist-assisted training prompts greater improvement in walking ability than does training provided by a robotic device, according to an article in the June issue of Stroke, posted online on May 8. |
|
Cognitive abilities ease impact of Alzheimer pathology May 9, 2008
NEW YORK (Reuters Health) - Mental processing resources, such as perceptual speed and working memory, can reduce the effect of Alzheimer disease (AD) pathology on other cognitive systems, according to a report in the April 22nd issue of Neurology. |
|
EARNINGS POLL-Solvay Q1 profit down on dollar, input costs May 9, 2008
BRUSSELS (Reuters) - Belgian drugs, chemicals and plastics maker Solvay will report a 9 percent fall in first-quarter operating profit on Tuesday due to the weak dollar, commodity price spikes and a depressed building sector. |
|
Sanofi hit by generic Plavix threat in Europe May 9, 2008
LONDON (Reuters) - French drugmaker Sanofi-Aventis, which briefly encountered generic competition to its second-biggest product Plavix in the United States in 2006 and 2007, now faces a similar threat in Europe. |
|
Naftidrofuryl beneficial for intermittent claudication May 9, 2008
NEW YORK (Reuters Health) - The peripheral vasodilator naftidrofuryl significantly improves functional capacity in patients with intermittent claudication, according to a meta-analysis conducted by the Cochrane Peripheral Vascular Diseases Group. |
|
Mylan posts bigger loss after charges; shares fall May 9, 2008
NEW YORK (Reuters) - Drugmaker Mylan Inc on Thursday reported a wider first-quarter loss due to lower U.S. sales of generic medicines and special charges, although overall revenue more than doubled after a recent acquisition. |
|
Hungary's Richter lowers sales outlook after Q1 May 9, 2008
BUDAPEST (Reuters) - Hungarian drug maker Richter Gedeon delivered first-quarter operating figures in line with market expectations on Friday but lowered its sales outlook for some key markets, including the U.S. and Hungary. |
|
Schweizerhall plans German generic Plavix launch May 9, 2008
LONDON (Reuters) - Schweizerhall, a generic drug company based in Basel, said on Friday it was close to winning approval for a generic version of Sanofi-Aventis's blockbuster blood thinning drug Plavix in Germany. |
|
Takeda sees big profit slump on Millennium costs May 9, 2008
TOKYO (Reuters) - Japan's Takeda Pharmaceutical Co Ltd posted a 7.7 percent fall in annual operating profit on Friday and forecast a sharp drop for the current year on costs for its $8.8 billion purchase of U.S. biotech firm Millennium Pharmaceuticals. |
|
Osiris to sell unit to NuVasive for up to $85 mln May 9, 2008
BANGALORE (Reuters) - Osiris Therapeutics Inc said it agreed to sell its Osteocel business to medical device maker NuVasive Inc for $85 million, including potential milestone payments, sending its shares up 15 percent. NuVasive will buy the business for $35 million in cash, and additional milestone-based payments of up to $50 million in either cash or a combination of cash and stock. |
|
 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
|   |
|
|
|
 |
|
Resources
